Ovarian transposition for the preservation of ovarian function in young patients with cervical carcinoma

Radiotherapy with or without survery for the treatment of pelvic malignancies irreversibly destroys the hormonal activity and reproductive capacity of ovaries in Young women. On the other hand, menopausal symptoms associated with estrogen deficiency is an important contributor to the poor quality of life scores in gynecologic cancer survivors. Transposing of the ovaries into the paracolic gutters (ovarian transposition) was described in 1958 with the aim of protecting gonadal functions in reproductive-aged women treated by pelvic radiotherapy and/or surgery. Although the laparatomic approach has been used as a parallel to development in endoscopic surgery, today it is generally performed laparoscopically. However, there is ongoing debate about the effectiveness of ovarian tranposition with respect to protecting gonadal functions. Moreover, metastasis to the transposed ovaries and port sites is another concern about this procedure. In this short review, indications, techniques and functional outcomes of ovarian transposition have been summarized.

Ovarian transposition; Cervical carcinoma; Radical hysterectomy; Fertility saving surgery; Pelvic malignancy; Laparoscopy.

[1] Martin K.A., Manson J.E.: "Approach to the patient with menopausal symptoms". J. Clin. Endocrinol. Metab., 2008, 93,4567.

[2] McCall M.L., Keaty E.C., Thompson J.D.: "Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery". Am. J. Obstet. Gynecol., 1958, 75, 590.

[3] Morice P., Haie-Meder C., Pautier P., Lhomme C., Castaigne D.:"Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: Report of two cases and surgical implications". Gynecol. Oncol., 2001, 83, 605.

[4] Simon B., Lee S.J., Partridge A.H., Runowicz C.D.: "Preserving fertility after cancer". CA Cancer J. Clin., 2005, 55, 211.

[5] Buekers T.E., Anderson B., Sorosky J.I., Buller R.E.: "Ovarian function after surgical treatment for cervical cancer". Gynecol.Oncol., 2001, 80, 85.

[6] Webb G.A.: "The role of ovarian conservation in the treatment of carcinoma of the cervix with radical surgery". Am. J. Obstet. Gynecol., 1975, 75, 590.

[7] Morice P., Castaigne D., Meder-Haie C., Pautier P., El Hassan J.,Duvillard P. et al.: "Laparoscoic ovarian transposition for pelvic malignancies:indication and funtional outcomes". Fertil. Steril.,1998, 70, 956.

[8] Yamamoto R., Okamoto K., Yukiharu R.U.T., Kaneuchi M., Negishi H., Sakurag N., Fujimoto S.: "A study of risk factors for ovarian metastases in Stage IB-IIIB cervical carcinoma and analysis of ovarian function after a transposition". Gynecol. Oncol.,2001, 82, 312.

[9] Dursun P., Ayhan A., Kuscu E.: "New surgical approaches for the management of cervical carcinoma". Eur. J. Surg. Oncol., 2008, 34, 487.

[10] Huang K.G., Lee C.L., Tsai C.S., Han C.M., Hwang L.L.: "A new approach for laparoscopic ovarian transposition before pelvic irradiation". Gynecol. Oncol., 2007, 105, 234.

[11] Feeney D.D., Moore D.H., Look K.Y., Stehman F.B., Sutton G.P.: The fate of ovaries after radical hysterectomy and ovarian transposition". Gynecol. Oncol., 1995, 56, 3.

[12] Kier R., Chambers S.K.: "Surgical transposition of the ovaries: imaging findings in 14 patients". A.J.R. Am. J. Roentgenol., 1989, 153, 1003.

[13] Chambers S.K., Chambers J.T., Holm C., Peschel R.E., Schwartz P.E.: "Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients". Gynecol. Oncol., 1990, 39, 155.

[14] Giacalone P.L., Laffargue F., Benos P., Dechaud H., Hedon B.: "Successful in vitro fertilization-surrogate pregnancy in a patient with ovarian transposition who had undergone chemotherapy andpelvic irradiation". Fertil. Steril., 2001, 76, 388.

[15] Steigrad S., Hacker N.F., Kolb B.: "In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy". Fertil Steril., 2005, 83, 1547.

[16] Oktay K., Economos K., Kan M., Rucinski J., Veeck L., Rosenwaks Z.: "Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to forearm". JAMA, 2001, 286, 1490.

[17] Falcone T., Attaran M., Bedaiwy M.A., Goldberg J.M.: "Ovarian function preservation in the cacer patients". Fertil. Steril., 2004, 81, 243.

[18] Tabata M., Ichinoe K., Sakuragi N., Shiina Y., Yamaguchi T., Mabuchi Y.: "Incidence of ovarian metastasis in patients with cancer of the uterine cervix". Gynecol. Oncol., 1987, 28, 255.

[19] Zivanovic O., Sonoda Y., Diaz J.P., Levine D.A., Brown C.L., ChiD.S. et al.: "The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease".Gynecol. Oncol., 2008, 111, 431.